Inventor · Paddy Lane, IL, US

Suzanne D. Conzen

14Patents
6h-index
6Co-inventors
55Inventor score

Filing activity: Mar 24, 2011 → Dec 15, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9289436B2 Method of treatment of prostate cancer with androgen receptor and glucocorticoid receptor antagonists Human Necessities 51 Active
US9149485B2 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer Human Necessities 37 Active
US8710035B2 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer Human Necessities 34 Active
US9623032B2 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer Human Necessities 32 Active
US9801893B2 Method of treatment for prostate cancer with androgen receptor antagonists and glucocorticoid receptor antagonists Human Necessities 32 Active
US10071130B2 Methods and compositions related to Hsp90 inhibitors and breast cancer Physics 6 Active
US10300076B2 Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists Human Necessities 4 Active
US10441596B2 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer Human Necessities 4 Active
US10729699B2 Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists after anticancer therapy Human Necessities 3 Active
US11234990B2 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer Human Necessities 2 Active
US11564932B2 Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists and anti-androgen receptor therapy Human Necessities 0 Active
US12062444B2 Methods and compositions related to triple-negative breast cancer Emerging Cross-Sectional Technologies 0 Active
US11883417B2 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer Human Necessities 0 Active
US12280066B2 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.